Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease

This publication has 95 references indexed in Scilit:

• Quantitation of the levels of tyrosine hydroxylase and preproenkephalin mRNAs in nigrostriatal sites after 6-hydroxydopamine lesions
  Life Sciences, 1993
• Increases in rat striatal preproenkephalin mRNA levels following chronic treatment with the depot neuroleptic, haloperidol decanoate
  Life Sciences, 1990
• Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
  New England Journal of Medicine, 1988
• Characterisation of messenger RNA extracted post-mortem from the brains of schizophrenic, depressed and control subjects.
  Journal of Neurology, Neurosurgery & Psychiatry, 1988
• Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the primate
  Life Sciences, 1987
• cDNA sequence of human β-preprotachykinin, the common precursor to substance P and neurokinin A
  FEBS Letters, 1986
• Lack of Change in Basal Ganglia Neuropeptide Content Following Subacute 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Treatment of the Common Marmoset
  Journal of Neurochemistry, 1986
• The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
• METHIONINE-ENKEPHALIN DEFICIENCY IN BRAINS OF PATIENTS WITH PARKINSON'S DISEASE
  The Lancet, 1981
• Topical distribution of the striatal efferents in the monkey
  Experimental Neurology, 1962